Search

Search Results

• Efficacy and Toxicity of Therapy for Patients with Intermediate-Risk Hodgkin’s Lymphoma: Results of Multicenter Randomized Study

  I.A. Kryachok, Alim Anvarovich Amdiev, I.B. Titorenko, E.M. Aleksik, E.O. Ul’yanchenko, O.I. Novosad, E.S. Filonenko, M.I. Kasich, M.Ya. Kiseleva

  281-286

  01.07.2015

• Multiple Myeloma: 7-Year Experience of Applying Targeted Therapy in Novosibirsk and Its Results

  T.I. Pospelova, Nataliya Valer’evna Skvortsova, I.N. Nechunaeva

  267-273

  01.07.2015

• Acute Myeloid Leukemias: 10-Year Therapy Experience

  Ol’ga Yur’evna Baranova, A.S. Antipova, O.D. Zakharov, N.A. Falaleeva, G.I. Kaletin, A.D. Shirin, G.R. Arakelyan, N.N. Tupitsyn, M.A. Frenkel’, N.A. Kupryshina, T.N. Obukhova, E.V. Domracheva, V.B. Larionova, E.V. Ogorodnikova, E.A. Osmanov

  287-301

  01.07.2015

• Autologous Stem Cell Transplantation in Primary Refractory Hodgkin’s Lymphoma: Supposed Zugzwang or Zwischenzug?

  Galina Dmitrievna Petrova, K.N. Melkova, T.Z. Chernyavskaya, N.V. Gorbunova, B.V. Afanas’ev, E.A. Demina, V.N. Kostrykina, V.A. Doronin

  321-330

  01.07.2015

• Surgical Treatment of Perianal Infectious Complications in Hematologic Clinic

  Svetlana Vital’evna Shtyrkova, S.R. Karagyulyan, K.I. Danishyan, S.K. Kravchenko, V.V. Troitskaya, L.A. Kuz’mina

  337-342

  01.07.2015

• Normal Hematopoiesis and Its Regulation

  Elena B. Vladimirsky

  109-119

  01.04.2015

• Role of Enzymatic Activity in Producing an Antiproliferative Effect of L-Asparaginases

  Vadim Sergeevich Pokrovskii, M.V. Komarova, S.S. Aleksandrova, M.V. Pokrovskaya, M.S. Kalish’yan, S.Sh. Karshieva, E.M. Treshchalina

  120-128

  01.04.2015

• Diagnostic Strategy for Detection of Typical and Atypical BCR-ABL Fusion Gene Transcripts in Chronic Myeloid Leukemia

  O.V. Nikulina, Grigorii Anatol’evich Tsaur, T.O. Riger, Yu.A. Yakovleva, A.S. Demina, E.R. Semenikhina, T.V. Spil’nik, LI Savel’ev, L.G. Fechina

  161-168

  01.04.2015

• Taxonomic Structure and Antibiotic Resistance of Bloodstream Infection Pathogens in Oncohematological Patients

  Natal’ya Sergeevna Bagirova

  191-200

  01.04.2015

• Positron Emission Tomography in Modern Management of Lymphomas

  I.P. Aslanidi, Ol’ga Valentinovna Mukhortova, T.A. Katunina, I.V. Ekaeva, M.G. Shavman

  13-25

  01.01.2015

• High-Dose Chemotherapy for Grade 3B Relapsed Follicular Lymphoma with Deletions of Loci of BCL6 (3q27) and TP53 (17p13) Genes: Case Report and Literature Review

  E.E. Zvonkov, Nelli Georgievna Gabeeva, M.V. Firsova, E.V. Moiseeva, V.V. Troitskaya, L.A. Kuz’mina, T.N. Obukhova, A.M. Kovrigina, E.N. Parovichnikova, V.G. Savchenko

  36–43

  01.01.2015

• Rare Disease — Nodular Lymphocyte-Predominant Hodgkin’s Lymphoma: Literature Review and Own Data

  E.A. Demina, G.S. Tumyan, A.A. Chekan, M.Yu. Kichigina, A.S. Antipova, N.A. Probatova, A.I. Pavlovskaya, N.V. Kokosadze, A.M. Kovrigina, O.P. Trofimova, E.A. Osmanov

  522-532

  01.10.2014

• Allogeneic Hematopoietic Stem Cell Transplantation in Myelodysplastic Syndromes and Clinical Significance of WT1 Gene Overexpression

  N.N. Mamaev, A.V. Gorbunova, T.L. Gindina, E.V. Morozova, Ya.V. Gudozhnikova, O.A. Slesarchuk, V.N. Ovechkina, A.A. Rats, E.G. Boichenko, E.A. Ukrainchenko, V.M. Kravtsova, A.V. Evdokimov, I.M. Barkhatov, S.N. Bondarenko, B.V. Afanas’ev

  551-563

  01.10.2014

• Rationale for Maintenance Treatment of Patients with Acute Myeloid Leukemia below 65 Years of Age, According to Data of a Retrospective Analysis of Protocols AML-2000 and AML-2007

  S.V. Semochkin, T.N. Tolstykh, V.V. Lunin, N.K. Khuazheva, A.I. Kostin, S.A. Chernysh, M.E. Pochtar, V.L. Ivanova

  564-572

  01.10.2014

• Quality of Life of Patients with Lymphomas at Different Time-Points after High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation

  N.E. Mochkin, D.A. Fedorenko, V.Ya. Mel’nichenko, T.I. Ionova, T.P. Nikitina, K.A. Kurbatova, A.A. Novik

  577-582

  01.10.2014

• Imatinib Generics: Myths and Reality (Literature Review and Our Experience)

  K.M. Abdulkadyrov, V.A. Shuvaev, M.S. Fominykh

  311-316

  01.07.2014

• High-Dose Chemotherapy and Autologous Stem Cells Transplantation for Relapsed/Refractory Hodgkin’s Lymphoma. Is There an Equal Right to Life?

  N.V. Zhukov, A.G. Rumyantsev, A.L. Uss, N.F. Milanovich, V.V. Ptushkin, B.V. Afanasyev, N.B. Mikhaylova, V.B. Larionova, E.A. Demina, E.E. Karamanesht, N.G. Tyurina, M.A. Vernyuk, A.D. Kaprin

  317-326

  01.07.2014

• Role of Catalase in Protection of Cancer Cells from Oxidative Stress induced by Binary Catalytic System “Teraphtal + Ascorbic acid”

  Т.А. Sidorova, M.S. Vagida, O.L. Kaliya, G.K. Gerasimova

  282-289

  01.07.2014

• Role of Bendamustine in Treatment of Multiple Myeloma

  O.M. Votyakova

  301-310

  01.07.2014

• Efficacy of platelet transfusions during standard induction chemotherapy in patients with acute myeloid leukemia

  B. Davaasambuu, S.V. Gritsayev, T.V. Glazanova, S.A. Tiranova, N.A. Potikhonova, I.S. Martynkevtch, A.V. Chechetkin

  213-219

  01.04.2014

• Management of relapsed and refractory multiple myeloma: literature review and our data. Part III

  S.S. Bessmeltsev

  137-174

  01.04.2014

• Organization of specialized medical care for patients with blood disorders in Saint Petersburg

  L.U. Zhiguleva, К.М. Abdulkadyrov

  1-8

  01.01.2014

• Rituximab (MabThera) for subcutaneous administration, new opportunities well-studied drug

  G.S. Tumyan

  67-70

  01.01.2014

• Genfatinib® therapy for chronic-phase chronic myeloid leukemia in routine clinical practice

  T.V. Chagorova, V.V. Yablokova, P.A. Borkina, N.A. Pryanikova

  434-438

  01.10.2013

• Hematopoietic stem cell transplantation in AML patients with t(8;21)(q22;q22) translocation

  N.N. Mamayev, A.V. Gorbunova, T.L. Gindina, I.M. Barkhatov, S.N. Bondarenko, M.Yu. Averyanova, О.V. Pirogova, O.V. Goloshchapov, Ye.V. Kondakova, B.V. Afanasyev

  439-444

  01.10.2013

• Mantle cell lymphoma: program therapy for untreated patients under 65 years

  V.I. Vorobyev, S.K. Kravchenko, E.G. Gemdjian, Yu.Yu. Lorie, A.U. Magomedova, A.L. Melikyan, J.K. Mangasarova, D.S. Mar’yin, E.I. Dubrovin, T.N. Obukhova, S.A. Makhinya, V.A. Zherebtsova, M.A. Vernyuk, N.G. Tyurina, V.G. Savchenko

  274-281

  01.07.2013

• International prognostic score in advanced Hodgkin’s lymphoma

  K.D. Kaplanov, A.L. Shipaeva, V.A. Vasil’yeva, E.G. Gemdjian, I.V. Matveeva, L.S. Tregubova, T.U. Klitochenko, K.V. Demidenko, O.B. Kalashnikova, G.U. Vyskub, O.E. Golubeva, O.V. Levina, V.A. Orlov, E.A. Demina

  294-302

  01.07.2013

• Cytogenetic remission as an important criterion for treatment efficacy in pediatric acute myeloid leukemia

  E.W. Fleischman, O.I. Sokova, A.V. Popa, V.S. Nemirovchenko, L.N. Konstantinova, N.F. Metelkova

  148-156

  01.04.2013

• Chronic hepatitis B and hematological malignancies

  A.O. Buyeverov, P.O. Bogomolov

  210-216

  01.04.2013

• Chimerism following allogeneic hematopoietic stem cell transplantation

  O.V. Blau

  34-39

  01.01.2013

• Management of refractory acute lymphoblastic leukemia in children and adolescents: remission re-induction followed by allogeneic hematopoietic stem cell transplantation

  E.V. Semenova, N.V. Stancheva, S.N. Bondarenko, V.N. Vavilov, D.A. Bagge, O.V. Paina, S.V. Razumova, A.S. Borovkova, T.A. Bykova, A.A. Raths, L.S. Zuborovskaya, B.V. Afanasyev

  53-59

  01.01.2013

• Cardiovascular complications of chronic myeloid leukemia treated with tyrosine kinase inhibitors

  G.E. Gendlin, L.M. Makeeva, E.I. Emelina, K.V. Shuikova, G.I. Storozhakov

  78-84

  01.01.2013

• Use of rituximab for treatment of HIV-infected patients with hematological disorders

  A.V. Pivnik

  85-91

  01.01.2013